Avanza Capital Proudly Announces Attorney Anthony Varbero’s Appointment to New York City Bar Association’s Structured Finance Committee

New York, NY, Dec. 17, 2025 (GLOBE NEWSWIRE) — Avanza Capital Holdings is proud to announce that Attorney Anthony Varbero has been appointed to the prestigious New York City Bar Association Structured Finance Committee, serving a term from December 11, 2025 through July 31, 2027. This honor recognizes Varbero's legal expertise and his growing influence […]

Avanza Capital Proudly Announces Attorney Anthony Varbero’s Appointment to New York City Bar Association’s Structured Finance Committee

Avanza Capital Proudly Announces Attorney Anthony Varbero's Appointment to New York City Bar Association's Structured Finance Committee GlobeNewswire December 17, 2025 New York, NY, Dec. 17, 2025 (GLOBE NEWSWIRE) — Avanza Capital Holdings is proud to announce that Attorney Anthony Varbero has been appointed to the prestigious New York City Bar Association Structured Finance Committee,

Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight

The ulcerative colitis market is experiencing steady growth driven by rising disease prevalence and increasing diagnosis rates worldwide. Expanding adoption of advanced biologics, small-molecule therapeutics, and targeted immunomodulators is significantly boosting market revenues. Additionally, the expected launch of therapies such as obefazimod (Abivax), tulisokibart (Merck), Afimkibart (RVT 3101) (Roche), MORF-057 (Eli Lilly), and others will

Repurchased own ordinary shares reached 5% of Tenaris’s voting rights; Tenaris’s controlling shareholder files amendment to Schedule 13D

(NYSE:TS),(Milan:TEN),(BMV:TS.MX), LUXEMBOURG, Dec. 17, 2025 (GLOBE NEWSWIRE) — Pursuant to applicable Luxembourg Transparency Law requirements, Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris” or the “Company”) announces that on December 17, 2025, the proportion of own ordinary shares acquired under its share buyback program and currently held in treasury has reached 5.07%

Repurchased own ordinary shares reached 5% of Tenaris’s voting rights; Tenaris’s controlling shareholder files amendment to Schedule 13D

Repurchased own ordinary shares reached 5% of Tenaris's voting rights; Tenaris's controlling shareholder files amendment to Schedule 13D GlobeNewswire December 17, 2025 LUXEMBOURG, Dec. 17, 2025 (GLOBE NEWSWIRE) — Pursuant to applicable Luxembourg Transparency Law requirements, Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris” or the “Company”) announces that on December 17,

Burned by Firefly Aerospace Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back

NEW YORK, NY / ACCESS Newswire / December 17, 2025 / – SueWallSt: Class Action Filed Against Firefly Aerospace Inc. – Contact Levi & Korsinsky This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired: (a) Firefly common stock pursuant and/or traceable to

Nukkleus Inc. Receives Shareholder Approval to Acquire Star 26 Capital Inc.

(NasdaqGM:NUKK),(TASE:WATR.TA), NEW YORK and TEL AVIV, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense (A&D) industry, today announced that its stockholders have approved the acquisition of Star 26 Capital Inc., a defense-focused acquisition company. The

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of November 2025

(NasdaqGM:BANX), DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) — ArrowMark Financial Corp., (NASDAQ: BANX) (“ArrowMark Financial”), today announced that BANX's estimated and unaudited Net Asset Value (“NAV”) as of November 30, 2025, was $22.60. This estimated NAV is not a comprehensive statement of our financial condition or results for the month ended November 30, 2025. About

Nukkleus Inc. Receives Shareholder Approval to Acquire Star 26 Capital Inc.

Nukkleus Inc. Receives Shareholder Approval to Acquire Star 26 Capital Inc. GlobeNewswire December 17, 2025 NEW YORK and TEL AVIV, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense (A&D) industry, today announced that its stockholders

Scroll to Top